Free Trial

Revolution Medicines (RVMD) Competitors

Revolution Medicines logo
$54.10 +4.42 (+8.90%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$54.30 +0.20 (+0.37%)
As of 10/17/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RVMD vs. ONC, INSM, BNTX, TEVA, GMAB, SMMT, ASND, RDY, VTRS, and ROIV

Should you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include BeOne Medicines (ONC), Insmed (INSM), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry.

Revolution Medicines vs. Its Competitors

Revolution Medicines (NASDAQ:RVMD) and BeOne Medicines (NASDAQ:ONC) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Revolution Medicines had 4 more articles in the media than BeOne Medicines. MarketBeat recorded 15 mentions for Revolution Medicines and 11 mentions for BeOne Medicines. BeOne Medicines' average media sentiment score of 1.10 beat Revolution Medicines' score of 0.78 indicating that BeOne Medicines is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revolution Medicines
7 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BeOne Medicines
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Revolution Medicines has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, BeOne Medicines has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500.

Revolution Medicines has higher earnings, but lower revenue than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution Medicines$11.58M873.31-$600.09M-$4.50-12.02
BeOne Medicines$3.81B9.10-$644.79M-$1.73-182.90

Revolution Medicines has a net margin of 0.00% compared to BeOne Medicines' net margin of -3.89%. BeOne Medicines' return on equity of -1.22% beat Revolution Medicines' return on equity.

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A -41.78% -35.63%
BeOne Medicines -3.89%-1.22%-0.72%

Revolution Medicines presently has a consensus price target of $76.67, indicating a potential upside of 41.71%. BeOne Medicines has a consensus price target of $340.30, indicating a potential upside of 7.55%. Given Revolution Medicines' stronger consensus rating and higher probable upside, analysts clearly believe Revolution Medicines is more favorable than BeOne Medicines.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revolution Medicines
1 Sell rating(s)
0 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.93
BeOne Medicines
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.90

94.3% of Revolution Medicines shares are owned by institutional investors. Comparatively, 48.6% of BeOne Medicines shares are owned by institutional investors. 8.2% of Revolution Medicines shares are owned by company insiders. Comparatively, 6.6% of BeOne Medicines shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Revolution Medicines beats BeOne Medicines on 11 of the 16 factors compared between the two stocks.

Get Revolution Medicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVMD vs. The Competition

MetricRevolution MedicinesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$10.11B$3.44B$6.19B$10.56B
Dividend YieldN/A2.27%5.70%4.81%
P/E Ratio-12.0223.0185.5427.13
Price / Sales873.31481.75608.39130.24
Price / CashN/A46.9237.1060.81
Price / Book4.0210.4112.236.52
Net Income-$600.09M-$52.77M$3.33B$276.93M
7 Day Performance12.15%2.31%1.17%1.93%
1 Month Performance24.25%12.59%6.85%2.19%
1 Year Performance7.28%11.18%58.93%34.62%

Revolution Medicines Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVMD
Revolution Medicines
4.4092 of 5 stars
$54.10
+8.9%
$76.67
+41.7%
+7.3%$10.11B$11.58M-12.02250News Coverage
Analyst Forecast
Insider Trade
High Trading Volume
ONC
BeOne Medicines
2.9173 of 5 stars
$327.03
+2.2%
$340.30
+4.1%
N/A$35.08B$4.56B-189.0311,000
INSM
Insmed
2.9168 of 5 stars
$163.94
+1.0%
$149.06
-9.1%
+122.4%$34.31B$363.71M-28.711,271News Coverage
Positive News
Analyst Forecast
BNTX
BioNTech
2.6519 of 5 stars
$102.30
+0.2%
$134.32
+31.3%
-5.9%$24.54B$2.98B-63.946,772Analyst Forecast
TEVA
Teva Pharmaceutical Industries
3.5883 of 5 stars
$20.02
-0.1%
$25.57
+27.8%
+7.7%$22.97B$16.54B-125.0936,830
GMAB
Genmab A/S
3.6396 of 5 stars
$32.68
+2.7%
$40.80
+24.8%
+44.3%$20.42B$3.12B16.422,682Trending News
Analyst Forecast
Short Interest ↑
Analyst Revision
SMMT
Summit Therapeutics
3.003 of 5 stars
$22.93
+7.4%
$31.29
+36.4%
-1.0%$15.86B$700K-22.70110Upcoming Earnings
Gap Down
ASND
Ascendis Pharma A/S
2.8328 of 5 stars
$208.43
-0.5%
$248.29
+19.1%
+62.0%$12.93B$393.54M-40.391,017News Coverage
Analyst Upgrade
Analyst Revision
Gap Up
RDY
Dr. Reddy's Laboratories
3.0549 of 5 stars
$14.36
+0.1%
$16.95
+18.1%
-9.4%$11.97B$3.81B21.7527,811Positive News
VTRS
Viatris
3.055 of 5 stars
$9.86
+1.2%
$10.40
+5.5%
-13.5%$11.36B$14.74B-3.4032,000News Coverage
Analyst Forecast
ROIV
Roivant Sciences
2.9391 of 5 stars
$16.21
+1.1%
$19.94
+23.0%
+44.8%$10.95B$29.05M-23.16860Insider Trade

Related Companies and Tools


This page (NASDAQ:RVMD) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners